BrainStorm Cell Therapeutics Announces Full Year 2023 Financial Results and Provides Corporate Update

Conference call planned for early April 2024 to provide update on NurOwn program
NEW YORK, April 1, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell...

Related Keywords

California ,United States ,Stacy Lindborg ,Chaim Lebovits ,Lisa Guiterman ,Michael Wood ,Research Symposium ,Drug Administration ,European Medicines Agency ,California Institute For Regenerative Medicine ,Nasdaq ,National Ms Society ,Brainstorm Cell Therapeutics Inc ,Gene Therapies Advisory Committee ,Brainstorm Cell Therapeutics ,Biologics License Application ,Chief Executive Officer ,Special Protocol Assessment ,Scientific Conference ,Executive Vice President ,Chief Development Officer ,Biological License Application ,Year Ended December ,Storm Cell Therapeutics ,Orphan Drug ,California Institute ,Regenerative Medicine ,Regarding Forward Looking Statements ,Term Assets ,Term Liabilities ,Markets ,